Phosphatidylcholine-based nanoemulsions for paclitaxel and a p-glycoprotein inhibitor delivery and breast cancer intraductal treatment

HIGHLIGHTS

  • who: Giovanna Cassone Salata and Luciana B. Lopes from the Department of Pharmacology, Institute of Biomedical Sciences, University of Su00e3o Paulo, Sao Paulo, Brazil have published the paper: Phosphatidylcholine-Based Nanoemulsions for Paclitaxel and a P-Glycoprotein Inhibitor Delivery and Breast Cancer Intraductal Treatment, in the Journal: Pharmaceuticals 2022, 1110 of /2022/
  • what: In this study incorporation of the cytotoxic agent paclitaxel and the elacridar in hyaluronic acid (HA)-modified nanoemulsions was studied for intraductal and localized treatment. In the first part of this study, nanoemulsion composition was optimized, and the influence of composition on . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?